Pasithea Therapeutics (KTTA) Amortizatization of Intangibles (2023 - 2026)
Pasithea Therapeutics recorded quarterly Amortizatization of Intangibles of $157541.0 in Q1 2026, little changed quarter-over-quarter from $157541.0 in Q4 2025, and little changed year-over-year from $157541.0 in Q1 2025.
Pasithea Therapeutics' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $157541.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed 0.0% year-over-year to $157541.0; the TTM figure through Mar 2026 stood at $630164.0 (changed 0.0% YoY), while the FY2025 annual figure was $630164.0, changed 0.0% from the prior year.
- Amortizatization of Intangibles came in at $157541.0 for Q1 2026 at Pasithea Therapeutics, roughly flat from $157541.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $157541.0 in Q1 2023 to a low of $157541.0 in Q1 2023.
- A 4-year average of $157541.0 and a median of $157541.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 0.0% in 2024 and fell as far as 0.0% in 2024.
- Pasithea Therapeutics' Amortizatization of Intangibles stood at $157541.0 in 2023, then changed by 0.0% to $157541.0 in 2024, then changed by 0.0% to $157541.0 in 2025, then changed by 0.0% to $157541.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $157541.0, $157541.0, and $157541.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - | 157,541.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157,541.00 |
| Mar 31, 2026 | 157,541.00 |
| Dec 31, 2025 | 157,541.00 |
| Dec 31, 2025 | 157,541.00 |
| Sep 30, 2025 | 157,541.00 |
| Sep 30, 2025 | 157,541.00 |
| Jun 30, 2025 | 157,541.00 |
| Jun 30, 2025 | 157,541.00 |
| Mar 31, 2025 | 157,541.00 |
| Mar 31, 2025 | 157,541.00 |
| Dec 31, 2024 | 157,541.00 |
| Dec 31, 2024 | 157,541.00 |
| Sep 30, 2024 | 157,541.00 |
| Sep 30, 2024 | 157,541.00 |
| Jun 30, 2024 | 157,541.00 |
| Jun 30, 2024 | 157,541.00 |
| Mar 31, 2024 | 157,541.00 |
| Mar 31, 2024 | 157,541.00 |
| Dec 31, 2023 | 157,541.00 |
| Dec 31, 2023 | 157,541.00 |
| Sep 30, 2023 | 157,541.00 |
| Sep 30, 2023 | 157,541.00 |
| Jun 30, 2023 | 157,541.00 |
| Jun 30, 2023 | 157,541.00 |
| Mar 31, 2023 | 157,541.00 |
| Mar 31, 2023 | 157,541.00 |